Sight Sciences Return on Equity (ROE) Growth & History (SGHT)
Sight Sciences's return on equity was −50.74% for fiscal 2025.
View full Sight Sciences company overviewSight Sciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −50.74% | −1.15 pp |
| 2024 | 2024-12-31 | −49.59% | −9.95 pp |
| 2023 | 2023-12-31 | −39.64% | +4.35 pp |
| 2022 | 2022-12-31 | −43.98% | +43.92 pp |
| 2021 | 2021-12-31 | −87.90% | — |
Sight Sciences quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −8.33% | +7.85 pp |
| Q1 2026 | 2026-03-31 | −22.03% | −4.89 pp |
| Q4 2025 | 2025-12-31 | −6.49% | +6.49 pp |
| Q3 2025 | 2025-09-30 | −12.17% | −0.91 pp |
| Q2 2025 | 2025-06-30 | −16.18% | −4.48 pp |
| Q1 2025 | 2025-03-31 | −17.14% | −2.96 pp |
| Q4 2024 | 2024-12-31 | −12.98% | −4.34 pp |
| Q3 2024 | 2024-09-30 | −11.26% | −1.35 pp |
| Q2 2024 | 2024-06-30 | −11.69% | −1.25 pp |
| Q1 2024 | 2024-03-31 | −14.18% | −3.04 pp |
| Q4 2023 | 2023-12-31 | −8.65% | +1.51 pp |
| Q3 2023 | 2023-09-30 | −9.91% | +2.29 pp |
| Q2 2023 | 2023-06-30 | −10.45% | +1.37 pp |
| Q1 2023 | 2023-03-31 | −11.14% | −0.66 pp |
| Q4 2022 | 2022-12-31 | −10.15% | — |
| Q3 2022 | 2022-09-30 | −12.19% | — |
| Q2 2022 | 2022-06-30 | −11.81% | — |
| Q1 2022 | 2022-03-31 | −10.48% | — |
Sight Sciences return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Sight Sciences's return on equity increased from −87.90% to −50.74%, a change of +37.16 percentage points. The latest reported quarter, Q2 2026, shows −8.33%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sight Sciences source filings ↗